NCT02718001 2026-04-13Edwards EVOQUE Eos MISCEND StudyEdwards LifesciencesPhase NA Active not recruiting123 enrolled
NCT03502733 2026-04-13Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and LymphomaNational Cancer Institute (NCI)Phase 1 Active not recruiting64 enrolled
NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT06870487 2026-04-01A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersPfizerPhase 1 Active not recruiting6 enrolled
NCT04090619 2026-02-13Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary CaregiversM.D. Anderson Cancer CenterActive not recruiting192 enrolled
NCT03794635 2026-01-07An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About CancerMemorial Sloan Kettering Cancer CenterPhase NA Active not recruiting45 enrolled
NCT01552434 2025-10-14Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseM.D. Anderson Cancer CenterPhase 1 Active not recruiting155 enrolled